[HAPSENG] YoY TTM Result on 30-Jun-2010 [#2]

Stock
[HAPSENG] HAP SENG CONSOLIDATED BHD
Announcement Date
25-Aug-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
30-Jun-2010 [#2]
Profit Trend
QoQ- 78.55%
YoY- 36.39%
Quarter Report
Latest QR
Upcoming QR
HAPSENG's Result
HAPSENG's Financial Summary
View:
Show?
TTM Result
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 31/07/07 CAGR
Revenue 3,765,098 3,731,539 3,247,581 2,577,330 2,963,976 2,541,568 1,902,133 12.22%
PBT 776,417 616,580 577,130 330,025 276,652 1,140,106 202,610 25.47%
Tax -192,635 -135,471 -142,040 -43,821 -62,132 -136,449 -42,958 28.84%
NP 583,782 481,109 435,090 286,204 214,520 1,003,657 159,652 24.48%
-
NP to SH 540,978 391,933 323,683 218,419 160,141 946,500 143,045 25.19%
-
Tax Rate 24.81% 21.97% 24.61% 13.28% 22.46% 11.97% 21.20% -
Total Cost 3,181,316 3,250,430 2,812,491 2,291,126 2,749,456 1,537,911 1,742,481 10.70%
-
Net Worth 3,393,835 3,364,121 8,846,689 2,468,615 2,327,945 2,203,404 1,558,247 14.05%
Dividend
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 31/07/07 CAGR
Div 294,510 200,448 188,217 73,123 67,645 335,047 41,028 39.50%
Div Payout % 54.44% 51.14% 58.15% 33.48% 42.24% 35.40% 28.68% -
Equity
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 31/07/07 CAGR
Net Worth 3,393,835 3,364,121 8,846,689 2,468,615 2,327,945 2,203,404 1,558,247 14.05%
NOSH 2,082,107 2,170,400 1,878,277 563,610 563,667 563,530 583,613 23.96%
Ratio Analysis
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 31/07/07 CAGR
NP Margin 15.51% 12.89% 13.40% 11.10% 7.24% 39.49% 8.39% -
ROE 15.94% 11.65% 3.66% 8.85% 6.88% 42.96% 9.18% -
Per Share
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 31/07/07 CAGR
RPS 180.83 171.93 172.90 457.29 525.84 451.01 325.92 -9.47%
EPS 25.98 18.06 17.23 38.75 28.41 167.96 24.51 0.98%
DPS 14.14 9.24 10.02 13.00 12.00 59.45 7.00 12.60%
NAPS 1.63 1.55 4.71 4.38 4.13 3.91 2.67 -7.99%
Adjusted Per Share Value based on latest NOSH - 563,610
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 31/07/07 CAGR
RPS 151.23 149.88 130.44 103.52 119.05 102.08 76.40 12.22%
EPS 21.73 15.74 13.00 8.77 6.43 38.02 5.75 25.17%
DPS 11.83 8.05 7.56 2.94 2.72 13.46 1.65 39.47%
NAPS 1.3632 1.3512 3.5533 0.9915 0.935 0.885 0.6259 14.05%
Price Multiplier on Financial Quarter End Date
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 31/07/07 CAGR
Date 28/06/13 29/06/12 30/06/11 30/06/10 30/06/09 30/06/08 31/07/07 -
Price 2.05 1.80 1.75 0.96 0.83 0.92 1.09 -
P/RPS 1.13 1.05 1.01 0.21 0.16 0.20 0.33 23.10%
P/EPS 7.89 9.97 10.15 2.48 2.92 0.55 4.45 10.15%
EY 12.67 10.03 9.85 40.37 34.23 182.56 22.49 -9.23%
DY 6.90 5.13 5.73 13.54 14.46 64.62 6.42 1.22%
P/NAPS 1.26 1.16 0.37 0.22 0.20 0.24 0.41 20.88%
Price Multiplier on Announcement Date
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 31/07/07 CAGR
Date 19/08/13 30/08/12 24/08/11 25/08/10 26/08/09 26/08/08 27/09/07 -
Price 2.11 1.64 1.30 0.88 0.85 0.80 1.01 -
P/RPS 1.17 0.95 0.75 0.19 0.16 0.18 0.31 25.14%
P/EPS 8.12 9.08 7.54 2.27 2.99 0.48 4.12 12.14%
EY 12.31 11.01 13.26 44.04 33.42 209.95 24.27 -10.83%
DY 6.70 5.63 7.71 14.77 14.12 74.32 6.93 -0.56%
P/NAPS 1.29 1.06 0.28 0.20 0.21 0.20 0.38 22.92%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment